Supplementary Figure S4 from Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients

Corrine A. Nief, Phoebe M. Hammer, Aihui Wang, Vivek Charu, Amina Tanweer, Babak Litkouhi, Elizabeth Kidd, Andrew J. Gentles, Brooke E. Howitt
In: American Association for Cancer Research · 2024 · doi:10.1158/1078-0432.26134332 · W4400214944
preprint OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

The Endometrioid Endometrial RNA Index (EERI) score predicts recurrence-free survival in endometrioid endometrial cancer patients across stages I-IV, with specific analysis shown for each stage.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Supplemental Figure 4: Recurrence Free Survival stratified by EERI score for Stages I-IV disease in the TCGA-UCEC Cohort. Patients with EEC by stage at diagnosis. Patients were included with more than 1 year of follow-up and known endometrioid histology. A) Stage I patients. B) Stage II patients. C) Stage III patients. D) Stage IV patients. E) All stages.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK